Skip to main content
Have a personal or library account? Click to login
Postoperativna Pioderma Gangrenozum – Prikaz Slučaja Cover

References

  1. Almukhtar R, Armenta AM, Martin J, Goodwin BP, Vincent B, Lee B, et al. Delayed diagnosis of post-surgical pyoderma gangrenosum: a multicenter case series and review of literature. Int J Surg Case Rep. 2018;44:152-6.
  2. Zuo KJ, Fung E, Tredget EE, Lin AN. A systematic review of post-surgical pyoderma gangrenosum: identification of risk factors and proposed management strategy. J Plast Reconstr Aesthet Surg. 2015;68(3):295-303.
  3. Dhooghe N, Oieni S, Peeters P, D’Arpa S, Roche N. Post surgical pyoderma gangrenosum in flap surgery: diagnostic clues and treatment recommendations. Acta Chir Belg. 2017;117(2):69-76.
  4. Sasor SE, Soleimani T, Chu MW, Cook JA, Nicksic PJ, Tholpady SS. Pyoderma gangrenosum demographics, treatments, and outcomes: an analysis of 2,273 cases. J Wound Care. 2018;27(Suppl 1):S4-8.
  5. Touil LL, Gurusinghe DA, Sadri A, El-Gawad A, Fahmy FS. Postsurgical pyoderma gangrenosum versus necrotizing fasciitis: can we spot the difference? Ann Plast Surg. 2017;78(5):582-6.
  6. Binus AM, Qureshi AA, Li VW, Winterfield LS. Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients. Br J Dermatol. 2011;165(6):1244-50.
  7. Reichrath J, Bens G, Bonowitz A, Tilgen W. Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients. J Am Acad Dermatol. 2005;53(2):273-83.
  8. Tolkachjov SN, Fahy AS, Cerci FB, Wetter DA, Cha SS, Camilleri MJ. Postoperative pyoderma gangrenosum: a clinical review of published cases. Mayo Clin Proc. 2016;91(9):1267-79.
  9. Sakai H, Otsubo S, Iizuka H. Peristomal pyoderma gangrenosum associated with rectal adenocarcinoma. J Dermatol. 2006;33(1):68-70.
  10. Wollina U. Clinical management of pyoderma gangrenosum. Am J Clin Dermatol. 2002;3(3):149-58.
  11. Ahn C, Negus D, Huang W. Pyoderma gangrenosum: a review of pathogenesis and treatment. Expert Rev Clin Immunol. 2018;14(3):225-33.
  12. Marzano AV, Fanoni D, Antiga E, Quaglino P, Caproni M, Crosti C, et al. Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and Sweet’s syndrome. Clin Exp Immunol. 2014; 178(1):48-56.
  13. Marzano AV, Damiani G, Ceccherini I, Berti E, Gattorno M, Cugno M. Autoinflammation in pyoderma gangrenosum and its syndromic form (pyoderma gangrenosum, acne and suppurative hidradenitis). Br J Dermatol. 2017;176(6):1588-98.
  14. Quist SR, Kraas L. Treatment options for pyoderma gangrenosum. J Dtsch Dermatol Ges. 2017;15(1):34-40.
  15. Łyko M, Ryguła A, Kowalski M, Karska J, Jankowska-Konsur A. The pathophysiology and treatment of pyoderma gangrenosum: current options and new perspectives. Int J Mol Sci. 2024;25(4):2440.
DOI: https://doi.org/10.2478/sjdv-2025-0010 | Journal eISSN: 2406-0631 | Journal ISSN: 1821-0902
Language: English
Page range: 76 - 82
Submitted on: Jan 10, 2026
Accepted on: Mar 18, 2026
Published on: May 12, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 Nenad Vasić, Kristina Kostić, Damjan Slavković, Zoran Kostić, Nenad Petrov, Tatjana Radević, Lidija Kandolf, published by Serbian Association of Dermatovenereologists (SAD)
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.